Compare DNUT & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNUT | BME |
|---|---|---|
| Founded | 1937 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.2M | 547.5M |
| IPO Year | 2021 | 2005 |
| Metric | DNUT | BME |
|---|---|---|
| Price | $3.43 | $40.85 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.72 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 36.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,522,616,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.58 | $34.18 |
| 52 Week High | $5.73 | $42.74 |
| Indicator | DNUT | BME |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 33.54 |
| Support Level | $3.46 | $40.55 |
| Resistance Level | $3.48 | $42.55 |
| Average True Range (ATR) | 0.19 | 0.59 |
| MACD | 0.05 | -0.19 |
| Stochastic Oscillator | 46.34 | 16.82 |
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.